Global and United States Daratumumab Market Report & Forecast 2024-2031

Report ID: 1869300 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Daratumumab Product Introduction
    1.2 Global Daratumumab Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Daratumumab Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Daratumumab Sales in Volume for the Year 2017-2028
    1.3 United States Daratumumab Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Daratumumab Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Daratumumab Sales in Volume for the Year 2017-2028
    1.4 Daratumumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Daratumumab in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Daratumumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Daratumumab Market Dynamics
        1.5.1 Daratumumab Industry Trends
        1.5.2 Daratumumab Market Drivers
        1.5.3 Daratumumab Market Challenges
        1.5.4 Daratumumab Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Daratumumab Market Segment by Type
        2.1.1 100mg Injection
        2.1.2 400mg Injection
    2.2 Global Daratumumab Market Size by Type
        2.2.1 Global Daratumumab Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Daratumumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Daratumumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Daratumumab Market Size by Type
        2.3.1 United States Daratumumab Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Daratumumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Daratumumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Daratumumab Market Segment by Application
        3.1.1 Multiple Myeloma
        3.1.2 Diffuse Large B Cell Lymphoma
        3.1.3 Follicular Lymphoma
        3.1.4 Mantle Cell Lymphoma
        3.1.5 Other
    3.2 Global Daratumumab Market Size by Application
        3.2.1 Global Daratumumab Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Daratumumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Daratumumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Daratumumab Market Size by Application
        3.3.1 United States Daratumumab Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Daratumumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Daratumumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Daratumumab Competitor Landscape by Company
    4.1 Global Daratumumab Market Size by Company
        4.1.1 Top Global Daratumumab Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Daratumumab Revenue by Manufacturer (2017-2022)
        4.1.3 Global Daratumumab Sales by Manufacturer (2017-2022)
        4.1.4 Global Daratumumab Price by Manufacturer (2017-2022)
    4.2 Global Daratumumab Concentration Ratio (CR)
        4.2.1 Daratumumab Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Daratumumab in 2021
        4.2.3 Global Daratumumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Daratumumab Manufacturing Base Distribution, Product Type
        4.3.1 Global Daratumumab Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Daratumumab Product Type
        4.3.3 Date of International Manufacturers Enter into Daratumumab Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Daratumumab Market Size by Company
        4.5.1 Top Daratumumab Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Daratumumab Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Daratumumab Sales by Players (2020, 2021 & 2022)
5 Global Daratumumab Market Size by Region
    5.1 Global Daratumumab Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Daratumumab Market Size in Volume by Region (2017-2028)
        5.2.1 Global Daratumumab Sales in Volume by Region: 2017-2022
        5.2.2 Global Daratumumab Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Daratumumab Market Size in Value by Region (2017-2028)
        5.3.1 Global Daratumumab Sales in Value by Region: 2017-2022
        5.3.2 Global Daratumumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Daratumumab Market Size YoY Growth 2017-2028
        6.1.2 North America Daratumumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Daratumumab Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Daratumumab Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Daratumumab Market Size YoY Growth 2017-2028
        6.3.2 Europe Daratumumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Daratumumab Market Size YoY Growth 2017-2028
        6.4.2 Latin America Daratumumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Daratumumab Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Daratumumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Johnson＆Johnson
        7.1.1 Johnson＆Johnson Corporation Information
        7.1.2 Johnson＆Johnson Description and Business Overview
        7.1.3 Johnson＆Johnson Daratumumab Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Johnson＆Johnson Daratumumab Products Offered
        7.1.5 Johnson＆Johnson Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Daratumumab Industry Chain Analysis
    8.2 Daratumumab Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Daratumumab Distributors
    8.3 Daratumumab Production Mode & Process
    8.4 Daratumumab Sales and Marketing
        8.4.1 Daratumumab Sales Channels
        8.4.2 Daratumumab Distributors
    8.5 Daratumumab Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Daratumumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Daratumumab Market Trends
    Table 3. Daratumumab Market Drivers
    Table 4. Daratumumab Market Challenges
    Table 5. Daratumumab Market Restraints
    Table 6. Global Daratumumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Daratumumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Daratumumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Daratumumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Daratumumab Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Daratumumab Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Daratumumab Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Daratumumab Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Daratumumab Sales Share by Manufacturer, 2017-2022
    Table 15. Global Daratumumab Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Daratumumab Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Daratumumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab as of 2021)
    Table 18. Top Players of Daratumumab in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Daratumumab Product Type
    Table 20. Date of International Manufacturers Enter into Daratumumab Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Daratumumab Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Daratumumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Daratumumab Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Daratumumab Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Daratumumab Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Daratumumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Daratumumab Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Daratumumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Daratumumab Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Daratumumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Daratumumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Daratumumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Daratumumab Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Daratumumab Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Daratumumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Daratumumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Daratumumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Daratumumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Daratumumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Daratumumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Johnson＆Johnson Corporation Information
    Table 43. Johnson＆Johnson Description and Business Overview
    Table 44. Johnson＆Johnson Daratumumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Johnson＆Johnson Daratumumab Product
    Table 46. Johnson＆Johnson Recent Development
    Table 47. Key Raw Materials Lists
    Table 48. Raw Materials Key Suppliers Lists
    Table 49. Daratumumab Customers List
    Table 50. Daratumumab Distributors List
    Table 51. Research Programs/Design for This Report
    Table 52. Key Data Information from Secondary Sources
    Table 53. Key Data Information from Primary Sources
List of Figures
    Figure 1. Daratumumab Product Picture
    Figure 2. Global Daratumumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Daratumumab Market Size 2017-2028 (US$ Million)
    Figure 4. Global Daratumumab Sales 2017-2028 (K Pcs)
    Figure 5. United States Daratumumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Daratumumab Market Size 2017-2028 (US$ Million)
    Figure 7. United States Daratumumab Sales 2017-2028 (K Pcs)
    Figure 8. United States Daratumumab Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Daratumumab Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Daratumumab Report Years Considered
    Figure 11. Product Picture of 100mg Injection
    Figure 12. Product Picture of 400mg Injection
    Figure 13. Global Daratumumab Market Share by Type in 2022 & 2028
    Figure 14. Global Daratumumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Daratumumab Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Daratumumab Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Daratumumab Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Daratumumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Daratumumab Market Share by Type in 2022 & 2028
    Figure 20. United States Daratumumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Daratumumab Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Daratumumab Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Daratumumab Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Daratumumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Multiple Myeloma
    Figure 26. Product Picture of Diffuse Large B Cell Lymphoma
    Figure 27. Product Picture of Follicular Lymphoma
    Figure 28. Product Picture of Mantle Cell Lymphoma
    Figure 29. Product Picture of Other
    Figure 30. Global Daratumumab Market Share by Application in 2022 & 2028
    Figure 31. Global Daratumumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Daratumumab Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Daratumumab Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Daratumumab Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Daratumumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Daratumumab Market Share by Application in 2022 & 2028
    Figure 37. United States Daratumumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Daratumumab Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Daratumumab Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Daratumumab Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Daratumumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Daratumumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Daratumumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Daratumumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Daratumumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Daratumumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Daratumumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Daratumumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Daratumumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Daratumumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Daratumumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Daratumumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Daratumumab Value Chain
    Figure 76. Daratumumab Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson＆Johnson
Frequently Asked Questions
Daratumumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Daratumumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Daratumumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports